Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Commercial Kit Enables Rapid Assessment of Chromatin Structure

By LabMedica International staff writers
Posted on 13 Feb 2011
A commercial kit is now available that enables the rapid quantitative assessment of chromatin structure by quantitatively differentiating expressed (accessible) and silent (inaccessible) regions of the genome.

The Bio-Rad Laboratories (Hercules, CA, USA) EpiQ chromatin analysis kit was designed to complement existing epigenetic assays such as DNA methylation and chromatin immunoprecipitation. More...
These measurements detect whether epigenetic processes such as DNA methylation or histone modification have caused changes in gene expression.

The EpiQ chromatin analysis kit was designed to differentiate between genes that are being actively transcribed (euchromatin) and silent genes (heterochromatin). The selective nuclease provided in the kit can only act on euchromatin. The difference in the amount of DNA detected by the kit's PCR reagents before and after nuclease digestion reveals the extent to which the target gene is expressed.

The EpiQ kit includes buffers for cell permeabilization and in situ chromatin digestion, optimized nuclease, materials for genomic DNA purification, control assays (qPCR primers) for chromatin assessment of a reference (epigenetically silenced) and control (constitutively expressed) gene, and EpiQ Chromatin SYBR Green Supermix, a real-time PCR reagent designed to amplify genomic DNA.

The EpiQ kit permits assessment of chromatin structure in as few as 50,000 cultured cells within six hours, and it can generate quantitative chromatin structure information for multiple genomic elements.

"The EpiQ chromatin analysis kit provides researchers with an easy and fast way to quantify a gene's chromatin state,” said Viresh Patel, marketing manager for PCR reagents at Bio-Rad. "Using the kit, cancer, developmental, and stem cell biology researchers are able to glean direct information regarding the chromatin state that is associated with epigenetic marks such as DNA methylation and histone modifications for the first time."

Related Links:
Bio-Rad Laboratories



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.